close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar99Point73
Implied share price

Buy Undervalued by 61.0%

5% margin of safety What's this?

EV / EBITDA
Use Average
MRK
Merck & Co., Inc.
JNJ
Johnson & Johnson
Change
NVS
Novartis AG (ADR)
Change
PFE
Pfizer Inc.
Change
SGP
Schering-Plough Corporation
Change
14.17 9.04 12.21 13.2 11.9 25.26
All amounts in millions
from last financial year
         
Implied Share Price $99.73 $135.83 $87.53 $41.32 $14.65
Market Cap 171,277 322,696 212,603 207,930 118,198
Net Debt 12,985 -18,515 16,599 15,609 4,798
Enterprise Value (EV) 184,261 304,181 209,620 223,539 51,349
Revenue 39,498 70,074 50,359 48,851 18,502
EBITDA 20,379 24,918 15,880 18,788 2,033
Percent 51.6 % 35.6 % 31.5 % 38.5 % 11.0 %
EBIT 14,004 21,172 10,655 13,631 860
Percent 35.5 % 30.2 % 21.2 % 27.9 % 4.6 %
Balance Sheet          
Total Assets 101,677 133,411 131,556 167,381 28,117
Total Liabilities 57,001 62,261 54,510 102,661 17,588
Shareholders Equity 44,676 71,150 77,046 64,720 10,529.0

Price history

Comments

No comments yet. Login to comment.